Caffeine Content Assessment in Beverages and Food Supplements: Regulatory Challenges and Health Implications
ChemFoodChem · 2025
DOI: 10.1002/cfch.202500037 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemFoodChem, 2025. Verfasst von Leonie Rinke und 3 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study presents an analysis of caffeine content in food supplements and evaluates current regulatory frameworks against established safety guidelines. High‐caffeine products, particularly sports, and food supplements, were assessed for compliance with the safety opinion of the European Food Safety Authority (EFSA). The investigation during 2010–2025 revealed significant exceeding of safe caffeine levels (200 mg single dose; 400 mg daily consumption) in several supplement products ( n = 12), with some containing up to 1000 mg per daily dose. Analysis of notifications from the Rapid Alert System for Food and Feed (RASFF) across Europe identified 19 alerts related to excessive caffeine content, with seven classified as “serious risk.” The findings underscore the need for enhanced regulatory oversight of high‐caffeine products, particularly those combining caffeine with other stimulants, such as synephrine.
Zitieren
APA
Rinke, L., Kull, A., Bock, V., & Lachenmeier, D. W. (2025). Caffeine Content Assessment in Beverages and Food Supplements: Regulatory Challenges and Health Implications. ChemFoodChem. https://doi.org/10.1002/cfch.202500037
Vancouver
Rinke L, Kull A, Bock V, Lachenmeier DW. Caffeine Content Assessment in Beverages and Food Supplements: Regulatory Challenges and Health Implications. ChemFoodChem. 2025. doi:10.1002/cfch.202500037
BibTeX
@article{Rinke2025,
author = {Rinke, Leonie and Kull, Ann‐Kathrin and Bock, Verena and Lachenmeier, Dirk W.},
title = {Caffeine Content Assessment in Beverages and Food Supplements: Regulatory Challenges and Health Implications},
journal = {ChemFoodChem},
year = {2025},
doi = {10.1002/cfch.202500037}
}
EUVIMED